Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00645359 · ClinicalTrials.gov registry record
Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell Lymphoma
A clinical trial, sponsored by University of Michigan Rogel Cancer Center.
- Terminated
- Registry status
- 9
- Enrollment target
NCT00645359: Clinical Trial study, sponsored by University of Michigan Rogel Cancer Center.
NCT00645359 is a clinical trial that was terminated before completion, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00645359 was terminated before completion, sponsored by University of Michigan Rogel Cancer Center.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This research study is designed to test whether the results of a diffusion MRI scan performed after one cycle of chemotherapy for lymphoma can accurately predict the outcome of treatment for individual patients.
Primary Outcome
To assess whether changes in the apparent diffusion coefficient (ADC) during the early phase of chemotherapy are detectable in lymphoma, the ADC value will be calculated at the voxel level, on baseline and Day 8, and the mean difference will be calculated.
Interventions
- PROCEDURE diffusion MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2006-11 |
| Est. Completion | 2014-04 |
Why NCT00645359 stopped before completion
NCT00645359 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which diffusion MRI is the first listed.
NCT00645359 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00645359 about?
NCT00645359 is a clinical study titled "Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell Lymphoma". This research study is designed to test whether the results of a diffusion MRI scan performed after one cycle of chemotherapy for lymphoma can accurately predict the outcome of treatment for individual patients.
What is the current status of trial NCT00645359?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2006-11. Estimated completion is 2014-04.
What interventions are being tested in trial NCT00645359?
The interventions under investigation include: diffusion MRI (PROCEDURE).
Who is sponsoring clinical trial NCT00645359?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia